Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System–Biowaiver
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 107 (6) , 1478-1488
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- BDDCS Applied to Over 900 DrugsThe AAPS Journal, 2011
- A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and JapanMolecular Pharmaceutics, 2006
- Clinical Pharmacokinetics of RifabutinClinical Pharmacokinetics, 1995
- Pharmacokinetics of meso-2,3- dimercaptosuccinic acid in patients with lead poisoning and in healthy adultsThe Journal of Pediatrics, 1994
- Morphine Pharmacokinetics and Metabolism in HumansClinical Pharmacokinetics, 1993
- Improved Bioavailability of a New Oral Preparation of Medroxyprogesterone AcetateJournal of Pharmaceutical Sciences, 1991
- Absorption, disposition and preliminary metabolic pathway of 14C-rifabutin in animals and manJournal of Antimicrobial Chemotherapy, 1990
- Intestinal Absorption of Amiodarone in ManThe Journal of Clinical Pharmacology, 1990
- MESO-2,3-Dimercaptosuccinic Acid: Chemical, Pharmacological and Toxicological Properties of an Orally Effective Metal Chelating AgentAnnual Review of Pharmacology and Toxicology, 1990
- FOLIC ACID ABSORPTION IN PREGNANCYBJOG: An International Journal of Obstetrics & Gynaecology, 1975